Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-16-113943
Filing Date
2016-07-21
Accepted
2016-07-21 17:00:49
Documents
4
Effectiveness Date
2016-07-21

Document Format Files

Seq Description Document Type Size
1 S-8 v443865_s8.htm S-8 56983
2 EXHIBIT 4.3 v443865_4-3.htm EX-4.3 93092
3 EXHIBIT 5 v443865_ex5.htm EX-5 7422
4 EXHIBIT 23.1 v443865_ex23-1.htm EX-23.1 2488
  Complete submission text file 0001144204-16-113943.txt   160992
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-212619 | Film No.: 161777809
SIC: 2834 Pharmaceutical Preparations